BioGaia AB (publ)

OTCPK:BIOG.Y Stock Report

Market Cap: US$1.1b

BioGaia Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Theresa Agnew

Chief executive officer

SEK 8.7m

Total compensation

CEO salary percentage55.20%
CEO tenure1.7yrs
CEO ownershipn/a
Management average tenure4yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Theresa Agnew's remuneration changed compared to BioGaia's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

SEK 310m

Dec 31 2024SEK 9mSEK 5m

SEK 351m

Sep 30 2024n/an/a

SEK 337m

Jun 30 2024n/an/a

SEK 402m

Mar 31 2024n/an/a

SEK 371m

Dec 31 2023SEK 7mSEK 1m

SEK 365m

Compensation vs Market: Theresa's total compensation ($USD905.07K) is below average for companies of similar size in the US market ($USD3.98M).

Compensation vs Earnings: Theresa's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Theresa Agnew (58 yo)

1.7yrs
Tenure
SEK 8,732,000
Compensation

Ms. Theresa P. Agnew serves as President of BioGaia AB (publ) since September 2023 and serves as its Chief Executive Officer since 25 September 2023. She is a global business leader with consumer healthcar...

Leadership Team

NamePositionTenureCompensationOwnership
Peter Rothschild
Founder & Chairman7.1yrsSEK 1.36mno data
Theresa Agnew
CEO & President1.7yrsSEK 8.73mno data
Alexander Kotsinas
Executive VP & CFO5.5yrsSEK 3.66m0.0030%
$ 32.9k
Ludvig Milesson
Chief Operating Officer2.1yrsno data0.0012%
$ 13.7k
Gianfranco Grompone
Chief Scientific Officer and VP of Research & Development5.3yrsno datano data
Caroline Mofors
Chief Legal Officer2.3yrsno datano data
Linda Hagglund
Chief Marketing Officer4yrsno data0.0012%
$ 13.1k
Angelika Kjelldorff
Chief HR Officer6.3yrsno data0.00049%
$ 5.4k
Sebastian Heimfors
VP & Chief Commercial Officer3.2yrsno datano data
Jonathan Gromark
Sustainability Managerno datano datano data
Minna Tähtinen
Managing Director Finlandno datano datano data
Jennifer Cherry
Managing Director USAno datano datano data
4.0yrs
Average Tenure
52yo
Average Age

Experienced Management: BIOG.Y's management team is considered experienced (4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Peter Rothschild
Founder & Chairman7.1yrsSEK 1.36mno data
David E. Dangoor
Independent Deputy Board Chairman22.3yrsSEK 622.00k1.73%
$ 19.2m
Vesa Koskinen
Director2yrsSEK 290.00kno data
Barbro Friden
Independent Director2yrsSEK 290.00k0.00068%
$ 7.5k
Anthon Jahreskog
Independent Director10yrsSEK 439.00k0.0042%
$ 47.0k
Vanessa Rothschild
Director5yrsSEK 352.00k0.00016%
$ 1.8k
Benedicte Flambard
Independent Director3yrsSEK 290.00kno data
Outi Armstrong
Independent Director2yrsSEK 290.00kno data
4.0yrs
Average Tenure
54yo
Average Age

Experienced Board: BIOG.Y's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 08:27
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioGaia AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher UhdeABG Sundal Collier Sponsored
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Mattias HäggblomDanske Bank